Overview

Pediatric Subjects With Tinea Corporis

Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
The study is being done to see how well the study cream works when applied once a day to affected area of child (where they have ringworm). The results will be compared to those seen with a placebo cream which has no active ingredient. Safety of the cream will also be measured.
Phase:
Phase 4
Details
Lead Sponsor:
Merz North America, Inc.
Merz Pharmaceuticals, LLC
Treatments:
Naftifine